New stock news | Xinde Technology submits application to Hong Kong Stock Exchange

According to the disclosure by the Hong Kong Stock Exchange on February 16, Shandong Xinde Technology Co., Ltd. (referred to as Xinde Technology) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with CICC and Zhongtai International as its joint sponsors. According to Zhishu Consulting's data, based on the revenue in 2024, the company is the ninth top domestic manufacturer in the Chinese animal health market and ranks in the top three in the Chinese poultry and livestock biological products market. According to the prospectus, founded in 1999, the company is a leading animal health company in China. The company is mainly engaged in the research and development, production, and sales of a full range of animal health and related products, including veterinary biological products (such as vaccines, antibodies, transfer factors, etc.), Chinese veterinary drugs, chemical drug formulations, animal feed and feed additives, to achieve prevention, diagnosis, treatment, and control of diseases in poultry, livestock, aquatic animals, and pets.